Nanomedicine News

RSS

Peer-Reviewed Nanomaterials and Nanotechnology Journal Receives 0.949 Impact Factor

Nanomaterials and Nanotechnology journal has received its first Journal Impact Factor of 0.949 as of July 29th, 2014. Up to this date, all journal's Volumes have been indexed in SCIE and Current Contents databases, as well as in Scopus.

30 Jul 2014

Nanoparticles Jumpstart Body's Ability to Fight Tumors

Researchers at Dartmouth-Hitchcock Norris Cotton Cancer Center are exploring ways to wake up the immune system so it recognizes and attacks invading cancer cells. Tumors protect themselves by tricking the immune system into accepting everything as normal, even while cancer cells are dividing and spreading.

26 Jul 2014

SapC-DOPS May be Used for Treatment of Brain Cancer

Over half of patients being seen in the clinic for a diagnosed brain tumor have metastatic cancer, which has no treatment and detrimental outcomes in most cases.

25 Jul 2014

NanoViricides Dedicates New R&D and cGMP Pilot Manufacturing Facility

NanoViricides, Inc. celebrated the grand opening of its new R&D and cGMP pilot manufacturing facility with Congressman Jim Himes as the Chief Guest yesterday, July 21.

From NanoViricides, Inc 24 Jul 2014

DNA-Wrapped Carbon Nanotube Can Detect Cancers Before Metastasization

Since they were first developed a quarter-century ago, carbon nanotubes (CNTs) have impressed scientists with their mechanical strength and stiffness, their optical performance, and their ability to conduct heat and electricity.

24 Jul 2014

New Material Holds Potential for Development of New Formulations of Rejected Drugs

More than 80 percent of all drug candidates in the pharma R&D suffer from poor solubility and are therefore rejected early in the drug discovery process.

23 Jul 2014

Novel Nano-Sized Vaccine Package Can Combat Dust-Mite Allergies

If you’re allergic to dust mites (and chances are you are), help may be on the way.

23 Jul 2014

Tekmira Preparing Complete Response to FDA for TKM-Ebola Phase I Clinical Hold

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, today announced an update on the TKM-Ebola Phase I clinical hold. The Company has received the clinical hold letter from the U.S. Food and Drug Administration (FDA) and is preparing a Complete Response to the Agency. The Company anticipates this matter will be resolved by Q4, 2014.

22 Jul 2014

Celator Broadens Application of CombiPlex Platform and CPX-351 for AML Treatment

Celator Pharmaceuticals, Inc., a pharmaceutical company developing new and more effective therapies to treat cancer, today will present updates on its lead candidate CPX-351 and CombiPlex® technology platform at its Analyst Day meeting for analysts and investors.

18 Jul 2014

Researchers Employ Magnetized Carbon Nanotubes to Extract Biomolecules from Live Cells

University of Houston researchers have devised a new method for extracting molecules from live cells without disrupting cell development, work that could provide new avenues for the diagnosis of cancer and other diseases.

18 Jul 2014

Nanomedicine News

Peer-Reviewed Nanomaterials and Nanotechnology Journal Receives 0.949 Impact Factor

Nanoparticles Jumpstart Body's Ability to Fight Tumors

SapC-DOPS May be Used for Treatment of Brain Cancer

NanoViricides Dedicates New R&D and cGMP Pilot Manufacturing Facility

DNA-Wrapped Carbon Nanotube Can Detect Cancers Before Metastasization

New Material Holds Potential for Development of New Formulations of Rejected Drugs

Novel Nano-Sized Vaccine Package Can Combat Dust-Mite Allergies

Tekmira Preparing Complete Response to FDA for TKM-Ebola Phase I Clinical Hold

Celator Broadens Application of CombiPlex Platform and CPX-351 for AML Treatment

Researchers Employ Magnetized Carbon Nanotubes to Extract Biomolecules from Live Cells

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Sustainable Carbon Nanomaterial Gii Set to Transform Energy Storage in Internet of Things Devices

Brain-Inspired Nano-Tech Promises New Era for Electronics

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials